Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAPB for Thoracic Surgery Pain
NCT03240562Completed
- Sponsor
- Samsung Medical Center
- Start
- Aug 2017
- Primary completion
- Nov 2017
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by Samsung Medical Center. Primary endpoint: Cumulative opioid consumption at 24 hours. Started Aug 2017; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03240562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03240562.